Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Experimental Therapeutics by targeting Spleen Tyrosine Kinase
Gene-Environment Interplay in the Development of Drug Abuse, HIV Sexual Risk Beha
Health Values and Minimally Important Differences in Systemic Sclerosis
Expression Studies Of Other Unconventional Myosins
Discriminative Stimulus Effects of Nicotine
Recently added grants:
Molecular Biology and Genetics Core
Circadian regulation of vascular aging
Pre-Clinical Models of VILI /ARDS Core
Protein Chemistry & Biophysics Core
Dysregulation of the NFkB/Sox18 Axis During Ventilator-Induced Lung Injury (VILI)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-000
Application #
6688657
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant